Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28759153 | 0.77 | ALDH1A1 (0.39) | HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13649516 | 0.77 | HSD11B1 (0.36) | HSD11B1 | |
| SCHEMBL29672411 | 0.76 | HSD11B1 (0.39) | HSD11B1 | |
| SCHEMBL11247806 | 0.74 | TSHR (0.30) | — | |
| SCHEMBL14149354 | 0.73 | HSD11B1 (0.37) | HSD11B1 | |
| SCHEMBL14559538 | 0.73 | HSD11B1 (0.55) | HSD11B1 | |
| SCHEMBL17008352 | 0.70 | ALDH1A1 (0.44) | HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL1524030 | 0.69 | ALDH1A1 (0.42) | HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL549021 | 0.69 | ALDH1A1 (0.42) | HSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL15922930 | 0.69 | ALDH1A1 (0.42) | HSD11B1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7312354-B2 | Adamantane derivative and production process for the same | IDEMITSU KOSAN CO., LTD. (JP) | 2007-12-25 | — | — | US | disclosed |
| EP-1731504-A1 | ADAMANTANE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-20060167302-A1 | Adamantane derivative and production process for the same | IDEMITSU KOSAN CO., LTD (JP) | 2006-07-27 | — | — | US | disclosed |
| JP-2006045161-A | 2-CYANOMETHYL-2-ADAMANTYL ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME | TOKUYAMA CORP | 2006-02-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060167302-A1 | Adamantane derivative and production process for the same | DDAH1, RIMKLA, MEP1A | HSD11B1 2047/4885ALDH1A1 176/4885SMN1; SMN2 3266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.